As shown in the heatmap (Fig. 8d), all the 24 decreased genera in GOS–BC treatment compared to FOS–BC treatment displayed positive correlation with several metabolites (between 54 and 56 metabolites). The gene discussed is FOS; the disease is breast cancer.